The distribution and roles of the cannabinoid CB2 receptor in the CNS are still a matter of debate. Recent data suggest that, in addition to its presence in microglial cells, the CB2 receptor may be also expressed at low levels, yet biologically relevant,
M Teresa Grande +2 more
exaly +4 more sources
Cannabichromene is a cannabinoid CB2 receptor agonist [PDF]
BACKGROUND Cannabichromene (CBC) is one of the most abundant phytocannabinoids in Cannabis spp. It has modest anti-nociceptive and anti-inflammatory effects and potentiates some effects of Δ9-tetrahydrocannabinol (THC) in vivo.
Michael Udoh +4 more
semanticscholar +3 more sources
Crystal Structure of the Human Cannabinoid Receptor CB2 [PDF]
The cannabinoid receptor CB2 is predominately expressed in the immune system, and selective modulation of CB2 without the psychoactivity of CB1 has therapeutic potential in inflammatory, fibrotic, and neurodegenerative diseases. Here, we report the crystal structure of human CB2 in complex with a rationally designed antagonist, AM10257, at 2.8 Å ...
Suwen Zhao, Xiaoting Li, Yiran Wu
exaly +4 more sources
Cannabinoid (CB2) receptor deficiency reduces the susceptibility of macrophages to oxidized LDL/oxysterol-induced apoptosis* [PDF]
Macrophage apoptosis is an important process in the pathophysiology of atherosclerosis. Oxidized low-density lipoproteins (OxLDL) are a major component of lesions and potently induce macrophage apoptosis.
Natalie E. Freeman-Anderson +5 more
doaj +2 more sources
Brain cannabinoid CB2 receptor in schizophrenia.
BACKGROUND Neural endocannabinoid function appears to be involved in schizophrenia. Two endocannabinoid receptors, CB1 and CB2, are found in the brain and elsewhere in the body. We investigated roles of CB2 in schizophrenia.
H. Ishiguro +26 more
semanticscholar +4 more sources
The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. [PDF]
Endocannabinoids are released following brain injury and may protect against excitotoxic damage during the acute stage of injury. Brain injury also activates microglia in a secondary inflammatory phase of more widespread damage. Most drugs targeting the acute stage are not effective if administered more than 6 hours after injury.
J. Ashton, M. Glass
semanticscholar +3 more sources
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory [PDF]
Neurocognitive effects of cannabinoids have been extensively studied with a focus on CB1 cannabinoid receptors because CB1 receptors have been considered the major cannabinoid receptor in the nervous system. However, recent discoveries of CB2 cannabinoid
Yong Li, Jimok Kim
doaj +2 more sources
Characterization of cannabinoid receptor ligands in tissues natively expressing cannabinoid CB2 receptors [PDF]
Background and PurposeAlthough cannabinoid CB2 receptor ligands have been widely characterized in recombinant systems in vitro, little pharmacological characterization has been performed in tissues natively expressing CB2 receptors. The aim of this study was to compare the pharmacology of CB2 receptor ligands in tissue natively expressing CB2 receptors
Pietro Marini +4 more
semanticscholar +3 more sources
Protocol for crystal structure determination of the antagonist-bound human cannabinoid receptor CB2
Summary: Human cannabinoid receptor CB2 plays an important role in the immune system and is an attractive therapeutic target for pain and for inflammatory and neurodegenerative diseases.
Ling Shen +5 more
doaj +2 more sources
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent [PDF]
Katherine E Hanlon,1,2 Alysia N Lozano-Ondoua,1 Puja J Umaretiya,1 Ashley M Symons-Liguori,1 Anupama Chandramouli,1 Jamie K Moy,1 William K Kwass,1 Patrick W Mantyh,1 Mark A Nelson,3 Todd W Vanderah,11Department of Pharmacology, University of Arizona ...
Hanlon KE +9 more
doaj +3 more sources

